As of April 2024 Teva Pharmaceutical Industries has a market cap of $14.56 Billion. This makes Teva Pharmaceutical Industries the world's 1174th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $14.56 B | 22.94% |
2023 | $11.84 B | 16.97% |
2022 | $10.12 B | 14.65% |
2021 | $8.83 B | -15.15% |
2020 | $10.41 B | -3.5% |
2019 | $10.79 B | -36.4% |
2018 | $16.96 B | -11.96% |
2017 | $19.26 B | -47.63% |
2016 | $36.79 B | -37.82% |
2015 | $59.17 B | 21.84% |
2014 | $48.56 B | 43.72% |
2013 | $33.79 B | 6.11% |
2012 | $31.84 B | -10.63% |
2011 | $35.63 B | -23.83% |
2010 | $46.78 B | -5.94% |
2009 | $49.74 B | 31.48% |
2008 | $37.83 B | 0.74% |
2007 | $37.55 B | 52.38% |
2006 | $24.64 B | -11.38% |
2005 | $27.81 B | 48.59% |
2004 | $18.71 B | 18.87% |
2003 | $15.74 B | 57.68% |
2002 | $9.98 B | 26.5% |
2001 | $7.89 B |
On Apr 19th, 2024 the market cap of Teva Pharmaceutical Industries was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Novartis NVS | $193.36 B | 1,227.51% | ๐จ๐ญ Switzerland |
Pfizer PFE | $147.22 B | 910.77% | ๐บ๐ธ USA |
Sanofi SNY | $116.48 B | 699.74% | ๐ซ๐ท France |
Merck MRK | $318.60 B | 2,087.35% | ๐บ๐ธ USA |
AstraZeneca AZN | $212.53 B | 1,359.14% | ๐ฌ๐ง UK |
GlaxoSmithKline GSK | $81.74 B | 461.20% | ๐ฌ๐ง UK |
Dr. Reddy's RDY | $11.90 B | -18.24% | ๐ฎ๐ณ India |